Equine Asthma Does Not Affect Circulating Myostatin Concentrations in Horses.

This research aims to investigate if the concentration levels of myostatin, a muscle growth regulator, in the blood can serve as an effective biomarker in the detection of equine asthma, a common and increasing problem in horses. The study found only marginal evidence to support this hypothesis and suggested further research to substantiate the findings.

Background

• The study examined the potential link between equine asthma and myostatin, a protein that controls muscle cell growth. The idea stemmed from existing human studies where higher levels of myostatin have been observed in asthma patients. The researchers explored the possibility of this protein serving as a biomarker in detecting asthma in horses.

Methods

• A total of 61 horses were evaluated clinically to ascertain or dismiss the presence of equine asthma. Additionally, a test called bronchoalveolar lavage (BAL) fluid cytology was performed on 49 horses. The methodology included dividing the horses into three categories – two consisting of healthy horses and the other one constituting horses with asthma.

Results

• The findings displayed that the mean myostatin concentration in the blood of asthmatic horses was considerably greater than those in healthy young racehorses.
• However, the myostatin levels in asthmatic horses showed no significant distinction compared to that of healthy adult leisure horses.

Conclusions

• The data collected did not conclusively substantiate the researchers’ starting premise that myostatin concentration could be a dependable marker for early detection of equine asthma.
• The authors maintain that the investigation is the first of its kind to scrutinize the relation between plasma myostatin levels and equine asthma and propagate the need for additional studies to authenticate the initial findings.